Novabay Pharmaceuticals IncのCurrent ratio
Novabay Pharmaceuticals IncのCurrent ratioは何ですか。
Novabay Pharmaceuticals IncのCurrent ratioは0.62です。
Current ratioの定義は何ですか。
流動比率は、同社が短期債務を履行するために十分なリソースを持っているかどうかを測定流動性比率です。
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
NYSEMKTのセクタHealth CareにおけるCurrent ratioの企業と比べるNovabay Pharmaceuticals Inc
Novabay Pharmaceuticals Incは何をしますか。
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Novabay Pharmaceuticals Incと類似のcurrent ratio
- Axis Capital LtdのCurrent ratioは0.62です。
- Paragon GmbH & Co. KGaAのCurrent ratioは0.62です。
- Berry CorpのCurrent ratioは0.62です。
- AJ LucasのCurrent ratioは0.62です。
- Entergy Utility Enterprises IncのCurrent ratioは0.62です。
- Guoan InternationalのCurrent ratioは0.62です。
- Novabay Pharmaceuticals IncのCurrent ratioは0.62です。
- Brookfield BusinessのCurrent ratioは0.63です。
- Cracker Barrel Old Country Store IncのCurrent ratioは0.63です。
- Tingyi (Cayman Islands)のCurrent ratioは0.63です。
- China Dredging Environment ProtectionのCurrent ratioは0.63です。
- Verizon Communications IncのCurrent ratioは0.63です。
- Target CapitalのCurrent ratioは0.63です。